Showing results (1261-1270 of 1,520) with videos related to
Sort By:
Pageof 152
Blood Advances|February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphomaRahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenibRonan J Kelly, Arun Rajan, Jeremy Force, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2010
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancerRonan J Kelly, Deborah Draper, Clara C Chen, et al.Journal of the American Geriatrics Society|July 14, 2012
Comorbidity-polypharmacy scoring facilitates outcome prediction in older trauma patientsDavid C Evans, Charles H Cook, Jonathan M Christy, et al.British Journal of Haematology|July 20, 2004
Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in IsraelBatia Stark, Marta Jeison, Leticia Glazer Gabay, et al.Molecular & Cellular Proteomics : MCP|March 2, 2013
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohortNilofer Azad, Minshu Yu, Ben Davidson, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS)Mark N Polizzotto, Thomas S Uldrick, Kathleen M Wyvill, et al.Haematologica|June 20, 2015
Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practiceLauren M Curtis, Manuel B Datiles, Seth M Steinberg, et al.Cancer Research|May 8, 2007
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brainDiane Palmieri, Julie L Bronder, Jeanne M Herring, et al.Cancer Biology & Therapy|December 17, 2005
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumorsWilliam L Dahut, Nehal J Lakhani, James L Gulley, et al.Pageof 152